Northway Biotech is a flexible biologics CDMO with a facility in a Greater Boston area, a world-leading hub in the field of life sciences research and drug development.
Our global teams based in the US and Europe are exceptionally well-versed in all aspects of the biopharmaceutical value chain, from cell line development to commercial production and aseptic fill-finish.
Our brand new, state-of-the-art facilities include R&D labs for cell line development, USP and DSP processes establishment and analytical support. cGMP manufacturing suite with both single-use and stainless steel systems for upstream and downstream process development, formulation and fill-finish of microbial and mammalian cell culture-based products will be fully functional in 2021.
We are deeply invested in providing high quality, world-class CDMO services and long-term partnerships based on our blend of experience and openly collaborative project teams.